Low ATG4D expression could identify high-risk patients who might benefit from more aggressive treatment approaches or closer surveillance protocols; 2) Personalized treatment approaches: The differential expression of ATGs based on EBV status indicates that therapeutic strategies targeting autophagy might need to be tailored according to the EBV status of the tumor. The gene discussed is ATG4D; the disease is neoplasm.